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Providing  adequate  health  care  and  expanding  access  to care  are
crucial problems  in many developing  countries. Should gov-
ernments  direct  their efforts  to meeting  existing  costs through
cost recovery  mechanisms  or should  they  give priority to low-
ering the costs before trying to recover  them?
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This paper  ,-  a product  of the Population, Health, and Nutrition  Division, Population  and Human
Resources Department-is  part of a larger study undertaken by PRE of African health policy. Copies are
available free from the World Bank, 1818 H Street NW, Washington, DC 20433.  Please contact Otilia
Nadora, room S6-065, extension 31091 (41 pages, with figures and tables).
Many donor agencies, including the World Bank,  government health facilities.  Changing the
have tended to view the problem of financing  present system so that cost recovery becomes a
health'care services in d0  -loping countries As  a  significant proportion of actual expenditures
problem of cost recovery. -Policy reforms based  would be extremely difficult.
on this view have therefore focused on measures,
such as user charges a~nd  insurance, intended to  However, realistic possibilities exist for
generate additional revenues to meet recurrent  reducing the costs of pharmaceuticals, which
resource needs.  However, the potential to  accounted for over 50 percent of total health
actually reduce costs by eliminating waste in  expenditures in 1986. Brunet-Jailly's  analysis
health systems has not been given adequate  shows that with improved drug management
attention.  practices, Mali would not need additional
extemal aid to make drugs available in its health
The health care situation in Mall represents a  units and dispensaries. This example suggests
case study in the difficulties of providing effec-  that the therapy for improving public health
tive care in poor countries. The share of health  services should be based primarily on cost
expenditures in the government's budget  reduction, not simply cost recov.ery.
amounted to nearly 9 percent at the beginning of
the 1970s but has fallen to about half that level  The conditions that govem access to health
since then.  Households bear most of the burden  care and drugs in the poorest countries today are
of health financing, accounting for about 75  grossly inequitable.  Only cost redu,ion  can
percent of total sectoral expenditures in 1986.  diminish this enormous inequity an  -give the
poor better access to hlalth care services.: Such a
Revenues from user charges represent only a  focus on cost reduction is consistent with the
small fraction of operating expenditures in  goals of the Bamako Initiative.
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This study was prepared by a Mali team assembled by Professor J. Brunet-Jailly.
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Inspector  of Finance,  project chief.  Kafing Dlarra and  Seydou Coulibaly worked with
the team throughout the study.2-
Health  Financing  in  the  Poor  Countries:
Cost  Rovery  or  Cost  Reduction
The  problem  of  financing  health  services  in  the  developing  countries
is  currently  being  looked  at  as  one  of  cost  recovery.  This  is  the  approach
taken  by,  in  particular,  the  World  Bank,  whose  activities  as  a  pressure  group
are  currently  aimed  at  getting  the  countries  to  which  it  furnishes  health
assistance  to  undertake  four  policy  reforms:
- Charge  users  of  government  health  facilities,  especially  for  drugs
and  curative  care. "This  will  increase  the  resource  available  to
the  government  health  sector,  allow  more  spending  on  underfunded
programs,  encourage  better  quality  and  more  efficiency,  and  increase
access  for  the  poor"  (who  will  be  protected  by  reduced  fees  and  will
be  "the  principal  beneficiaries  of  expanding  resources  for  and
improved  efficiency  in  the  government  sector)."  (cf.  tII  p.  3).
- Provide  insurance  or other  risk  coverage,  "in  order  to  help
mobilize  resources  for  the  health  sector  while  simultaneously
protecting  households  from  large  financial  losses.  A  modest  level
of  cost  recovery  is  possible  without  insurance.  But  in  the  long
run,  insurance  is  necessary  to  relieve  the  government  budget  of  the
high  costs  of  expensive  curative  care;  governments  cannot  raise
government  hospital  charges  close  to  costs  uatil  insurance  is  widely
available."  (cf.  El]  p.  4).
- Use  nongovernment  resources  effectively.  "Encourage  the
nongovernment  sector  (including  nonprofit  groups,  private
physicians,  pharmacists,  and  other  heaith  practitioners)  to  provide
health  services  for  which  consumers  are  willing  to  pay. This  will
allow  the  government  to  focus  its  resources  on  programs  that  benefit
whole  communities  rather  than  particular  individuals...Any
prohibitions  or  restrictions  on  nongovernment  providers  should  be
reviewed.  Unnecessary  paper  work  and  the  regulations  relating  to
nonprofit  providers  should  be  reduced."  (cf.  (ll  p.  5).
- Decentralize  government  health  services.  Decentralize  planning,
budgeting  and  purchasing  for  government  health  services,
particularly  the  services  offering  private  benefits  for  which  users
are  charged.  When  setting  national  policies  and  programs,  use
market  incentives  where  possible  to  better  motivate  staff  and
allocate  resources.  Allow  revenues  to  be  collected  and  retained  as
close  as  possible  to  the  point  of  service  delivery.  This  will
improve  both  the  collection  of  fees  and  the  efficiency  of  the
service."  (cf.  [11  p.  6).
These  reforms  are  expected  to  have  a  favorable  impact  on  the
solution  of  three  essential  problems,  all  of  which  are  said  to  be  due  to  the
efforts  of  governments  to  cover  the  full  costs  of  health  care  for  everyone
from  gener:l  public  revenues:-3-
- insufficient  spending  on  cost-effective  health  activities;
- inefficient  use  of  resources  in  public  programs;
°  inequity  in  health-care  distribution.
The  World  bank  is  not,  however,  the  only  organization  to  preach  cost
recovery.  Since  1984  the  World  Health  Organization  has  concerned  itself  with
disseminating  these  ideas  (cf.  [21).  The  technical  discussions  that  took
place  during  the  Fortieth  World  Health  Assembly  (Geneva,  May  1987)  concerned
"economic  support  for  national  health-for-all  strategies,"  and  the  ways  of
increasing  health  services  financing  were  onr  that  occasion  were  grouped  into
four  categories:  public  revenues,  insurance  P''vjmes,  community  financing
schemes,  and  user  charging  (cf.  [31  pp.  62-79).  The  schemes  and  mechanisms
put  forward  under  the  heading  of  "community  financing",  while  highly  diverse,
have  one  feature  in  common:  the  effort  is  borne  by  the  people,  most  often  the
sick. In  other  words,  the  term  "community  financing,"  which  no  doubt  pleases
certain  experts  and  certain  audiences,  accords  perfectly  with  cost  recovery
systems  (and  even  sometimes  the  special  case  of  user  charging).
Similarly,  the  activity  announced  by  UNICEF  in  September  1987  under
the  title  "Bamako  Initiative"  is  based  on  recovering  a  multiple  of  the  cost  of
essential  drugs  and  thereby  generating  a  margin  sufficient  to  finance  certain
primary  health-care  activities  (cf.  (41,  [51,  (61.  The  fact  that  this
proposal  is  based  mainly  on  the  use  of  essential  drugs  is  not  without
significance:  this  explicitly  introduces  the  prospect  both  of  rationalizing
prescribing  to  some  degree,  very  necessary  in  all  countries  and  especiall  the
poorest,  and  of  a perhaps  decisive  reduction  in  average  prescription  cost.
On  reflection  it  is  clear  that  solution  of  the  problem  posed  by  the
inability  of  governments  to  finance  health  services  can  be  sought  in  two
directions:  the  view  can  be  taken  either  that  the  costs  are  a  given  and  new
financing  sources  must  be  found  to  cover  them  (direct:  cost  recovery,  or
indirect:  insurance),  or  that  costs  can  be  reduced  and  the  solution  lies  at
least  in  part  in  eliminating  waste  that  has  been  tolerated  up  to  now. Should
efforts  therefore  be  directed  to  recovering  costs  as  they  are  or  else  to  first
lowering  them  before  trying  to  recover  them?
In  the  following  pages  we  shall  examine  this  question  on  the  basis
of  a  detailed  analysis  of  a particular  case,  that  of  Mali,  organized  as
follows.  In  section  1 we  present  the  general  situation  in  Mali;  in  aection  2
examine  the  actions  to  help  resolve  the  problem  already  taken  or  discussed
with  the  object  of  mobilizing  new  resources,  and  evaluate  their  practical
impact;  in  section  3  assess  the  benefits  to  be  expected  from  eliminating
certain  sources  of  waste,  and  in  section  4  set  forth  the  broad  lines  of  a
recommendable  solution.
1.  The  Setting
Before  examining  the  problem  of  financing  recurrent  health  costs  in
Mali  we  need  to  recall  certain  features  of  Mali's  development  and  economic
situation  and  of  its  health  system.-4-
1.1 General  economic  situation
Mali  is  one  of .,e  world's  poorest  countries.  According  to  the
national  accounts  kept  by  the  international  organizations,  Mali's  GNP  per
capita,  estimated  at  $180  in  1986,  is  one-hundredth  that  of  Switzerland  or  the
United  States  and  one-tenth  that  of  Brazil  or  Mexico  ((71  p.  256-257).
According  to  studies  based  on  the  concept  of  purchasing  power  parity--which,
by  correcting  the  error  due  to  the  use  of  exchange  rates,  are  known  to  reduce
the  level  of  living  differences  between  countries  In  relation  to  the  current
measurements  ((81-in  1985  GDP  per  capita  in  Mali  was  3S  of  that  of  the  United
States  ([91,  table  23).
Mali  is  also  a  country  that  is  growing  poorer  as  the  years  go  by:
the  assessment-  of  purchasing  power  parity  indicate  that  Mali's  GDP  per  capita
has  fallen  co!;.-nuously  since  1964  from  what  its  1960-1963  level,  and  its
ratio  to  per  capita  GDP  in  the  United  States  has  fallen  by  half  (from  5.77X  in
1960  to  only  2.81S  in  1983;  as  we  shall  see  later,  the  3.21%  attcained  in  1984
was  due  to  external  aid  (cf.  (9],  table  23). The  following  graph  depicts  this
trend  and  compares  it  with  that  experienced  in  C8te  d'Ivoire.
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Source:  Based  on (91,  tables  17  and 23.
Mali is  also  a country  that  has  for  a long  time  received  substantial
aid: its  current  public  resource  management  problems  are  of  long  standing  and
were  known  to  every  Malian  official  and  international  expert;  however,  as  is
recognized  today  in  the  documents  drawn  up  in  preparation  for  the  inevitable
structural  adjustment,  they  have  been  masked,  since  the  1972-73  drought,  by
the  rapid  growth  in  external  aid  flows.  Even  though  this  inflow  apparently
leveled  off  at  the  beginning  of  the  1980s,  official  development  aid  alone
accounted  for  322  of  Mali's  GNP  in  1984  ((101  p.  238),  34.92  in  1985  (Ell]  p.
274)--the  absolute  world  record  for  each  of  those  two  years--and  22.7S  in  1986
([71  p.  298).-5-
The  large  volume  of this  aid  has  prevented  neither  poor  manAgement
nor  inexcusable  decisions. Poor  manajement  is a scourge  of a swollen  public
s-*ctor,  pluAndered  by its  staff,  which  has  piled  up increasing  deficits  and
payment  arrears. The inexcusable  decisions  are those  concerning  development
expenditure  all.zation. The  generous  donors  clearly  share  responsibility  here
with  the  Mali  authorities: thanks  to  the  good  understanding  between  them,  the
share  of development  expenditures  allocated  to  the  directly  productive  sectors
fell  from  46%  in 1981  to 292 in  1985  (for  agriculture  by itself,  from  33Z to
232). During  this  period  three  fourths  of the  growth  in foreign-financed
development  expenditure  was  accounted  for  by three  large  infrastructure
projects  (the  S6lingu6  dam,  Sevar6-Gao  highway  and  Manantali  dam),  all three
of which  it was  known  in  advance  would  have  very  low  rates  of return  (cf.  E12]
p.  39,  para.  32).
1.2 Health  situation,  and status  of the  health  system
The  health  sector  is  unable  to  post  exceptional  results  in these
circumstances.  Infant-child  mortality  in Bamako  continues  to  be  much higher
than  in  a number  of other  African  capital  cities  (cf.  the  graph  below,
reproduced  from (131.  p. 39),  even  though  it has  declined. On the  latter
point,  is  is  obviously  not  enough  to  point  to  the  "expansior  and  improvement
of  public  health  plant,  particularly  that  devoted  to  maternal  and  child  care"
((13  p. 91); it  wou 1d be necessary  to  document  the  expansion  and  improvement
not  of the  plant  but  of the  activities  for  which  it  was  designed,  which  could
be difficult  to  do.  It  would  then  be necessary  to  demonstrate  the
relationship  between  these  activitits  and their  supposed  results;  it is
clearly  impossible  to  do that  the  data  available  at this time.
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No one  knows  the  exact  infant  mortality  rate  for  Mali as a whole.
The following  table  reproduces  the  figures  found  in recent  World  Bank
publications:
Mali:  Infant  Mortality  Ra e
for  Certain  Years  Between  1960  and  1966
Reference  1960  1965  1982  1983  1984  1985  1986
(141  p. 17  210
(15]  p. 180  179  134
(lC1  p. 250  207  176
(161  p. 92-  184  148
t111  p.  288  200  174
[71  p. 320  207  144
The  variations  shown  in this  table  would  merely  demonstrate  the
fragility  of the  data  were it  not that  the  weakest  estimates  are  given  in the
publications  that  deal  specifically  with  demographics  and  population  policy.
For  its  part,  a document  prepared  under  the  aegis  of WHO  confines  itself  to
citing,  without  the  slightest  comment,  rates  (furnished  by surveys  of visibly
uneven  quality)  ranging  from  118  to 255  per  thousand  (cf. (17  pp. 28-29). The
national  documents  refer  to the  assessments  made  by the  international
organizations  or  unhesitatingly  use studies  done  by amateurs  (for  example
[181).
The  health  services  are  in a crisis,  as every  one  knows. A recent
survey  [18],  while  improving  on the  previous  Ministry  of Health  estimates  by
at least  502, leads  to extremely  low  utilization  rates  (cf.  [191  pp. 26-31):
for  the  4.8  million  residents  of districts  (cercles)  that  have  no hospital,
just  over 700,000  episodes  have  been counted  (but  are  thes  -oisodes  in the
true  sense?),  which  gives  a utilization  rate  of 152. For ,,u  2.8  million
people  living  in  cercleo  that  possess  a hospital,  just  over 1.5  million
episodes  were counted,  giving  a rate  of 55S. The  hospitalization  rate  ia at
most 1.4X.
It should  be noted  that  the  statistics  recording  staff  are in
pracice unable  to distinguish  between  contacts  (any  contact  between  a sick
person  and  a health  professional)  and  episodes  (or  new  patients). When some
written  trace  of the  activity  remains,  only  the  former  are  entered  in the
records  and totaled  in the  statistical  statements  under  the  heading  of
episodes  (whereas  they  obviously  relate  to  contacts);  and  when the  number  of
contacts  has to  be supplied,  the  number  of "episodes"  is  multiplied  by an
arbitrary  figure,  often  close  to 3.  As a result,  utilization  rates  are  always
greatly  overestimated. It follows  from  the  above  figures  that  certainly  less
than  one  Malian  in three  today  has  contact  with  the  health  services  during  the
course  of a year;  the  rate  was higher  than  1  out  of 2 in 1975  (cf. [201  p.
284;  see  also,  for  1974,  [21]  p. 43).-7-
The  breakdown  of the  health  services  reflectei  in these  figures  has
no  doubt  been  occurring  in  most  of the  African  countries  over the  last  30
years.  In  Senegal,  for  example,  the  contacts  rate  was  over 100X  in 1960  and
was still  running  at 64X  in 1979,  in  which  year the  hospitalization  rate  was
around  31 (cf.  [221  pp.  13S-135).
In  light  of the  probable  mortality  rate  (see  above)  and the  few
systematic  epidemiological  surveys  (cf.  for  example  (241,  [251,  (261),  such
utilization  levels  are  an irrefutable  sign  that  the  health  system  takes  care
of only  a low,  even  a verv low,  percentage  of pathology. But the  technical
level  of the  care  provided  is  also  very  low: evidence  of this  is the  fact
that  paraclinical  examinations,  even the  most  elementary,  are  very little  used
(less  than  one  examination  per patient  hospitalized  in  a secondary  hospital
and  about  four  per  patient  in  a national  hospital  (cf.  [231  pp. 123-138)  and
th-t  the  diagnoses  traites  in the  national  hospitals  differ  very little  from
those  soigned  by the  arrondissement  and  cercle  health  centers  (cf.  (231
pp.  79-89).
These  general  observations  further  conceal  an important  phenomenon,
that  of inequity  in  access  to  health  care. The skew  in  favor  of the  cities  is
evident  in  Mali  as elsewhere: for  example,  there  is  one  midwife  for just  over
3,000  inhabitants  in Bamako,  against  nearly  80,000  in  the  Mopti  and  Sikasso
regions,  which  are  not the  most  disadvantaged  ones  (cf.  (281  p. 83);  moreover,
two  out  of three  midwives  in the  Mopti  region  are located  in  Mopti  itself  (cf.
(291  p. 32). Annual  government  health  expenditure  per  inhabitant  and per
cercle  retges  from  unde.  CFAF 70 to  over  CFAF  1,300  and  total  expenditure
from  under  CFAF 200  to  over  CFAF 9,500  (t271  p. 7).
This  situation  is  aggravated  by inequality  between  social  groups.
This  stems  from  a number  of factors,  including  clandestine  private  medical
practice,  accessible  only to those  with  the  ability  to  pay  for it,  provision
of free  health  care  to relatives  by public  health  service  steff,  and  the
privileges  enjoyed  by employees  of the  health  services  (or  of the  Social
Security  Institute  (INPS)  and their  families. While  these  phenomena  have  not
been fully  described,  concerning  the  second  and third  it is  known  that,  for
example,  77%  of biological  tests  run  by the  Public  Health  Research  Institute
(INRSP)  during  the  first  six  months  of 1987  were  done  for  patients  presented
as employees  of the  health  services  (the  large  majority  of them  of the  INRSP
itself)  or  members  of their  families  ((301). It  is  also known  that  60-701  of
lNPS  spending  on  pharmaceutical  purchases  is  consumed  by  its  own  personnel
(see  2.2  below). Finally,  it is  known  that,  despite  purported  strict  control,
17.41  of  biological  tests  run  by the  laboratory  of the  Point  G hospital  in
1988  were  done  on behalf  of its  staff  (cf.  (311  p. 27).
1.3  Health  financing
Even  today  some  people  apparently  still  believe  that  health  care is
free  in  Mali  and  government  pays  practically  the  whole  of its  cost. That is
not  the  case  at  all.
We cannot  ascertain  precisely  what the  situation  was 20  or 30  years
ago.  What  is  clear  is  that the  government  effort  has  declined  continuously,
certainly  since  1970:  detailed  anaLysis  of the  available  data  on the  budget
of  the  Ministry  of Public  Health  (cf.  (231  pp. 181-186)  indicates  that  theshare  of  health  expendLtuee  in  the  government  budget  (which  comprises  both  the
budget  of  the  miniLtries  and  national  administrations  and  that  of  the  regLons)
was  nearly  9S  at  the  beginning  of  the  1970s  and  has  fallen  by  half  since
then. Only  artful  presentation  can  mask  this  situation,  which  is  summarized
in  the  following  graph:
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The  fact  is  that  health  expenditures  are  financed  essentially  by
families.  The  major  expendittre  component  by  far  is  purchases  of
pharmaceutical  products,  which  represent  a  much  heavier  drain  on  private
budgets  than  is  generally  imagined: whereas  the  value  of sales  iS  officially
of  the  order  of  CFAF  6  billion  (in  1986  and  1987),  equal  to  about  CFAF  800  per
capita,  the  pharmaceutical  expenditure  per  capita  indicated  by  the  direct
population  surveys  is  much  higher--more  than  double.  The  old  surveys  ([32a,
(331)  Lndicate  drug  expenditures  four  to  eight  0'*es  higher,  and  the  more
recent  surveys  ((341)  two  to  three  tlmes  higher,  than  the  official
pharmaceutical  sales  figure.
These  differences  are  explained  by  a  number  of  well-identified
phenomena.  These  include  the  sale  of  products  of  the  PPM  (Pharuarcle
Populaire  du  Mal,  a  public  agency  with  a monopoly  right  to import,  and  until
1986  to  market,  drugs)  at  above  their  official  prices,  sale  of  products
imported  clandes.inely  from  several  neighboring  or  European  countriest  and
sale  to  the  public  of  products  forming  part  of  the  supplies  allocated  to
public  health  unLts  or  projects.  Whatever  the  mechanism,  the  drug  always  ends
up  being  paid  for  by  the  patient  or  tba  family.  It  has  to  be  concluded  that
the  direct  surveys  glve  a  better  pi..ture  of  the  situation  than  the  incomplete
statistics  normally  used  and  that  families  pay  at  least  CFAF  12  billion  for
modern  drugs,  whether  prescribed  or  self-administered.
The  second  major  item  is traditional  medicine.  Some  figures  put
forward  reflect  more  the  favor  it  enjoys  among  politicians  and  certain
experts--at  least  to  the  extent  that  it  asks  nothing  more  of  the  Government
than  fine  words--than  a  concern  to  arrive  at  a  realistic  assesst  -t.  On the
basis  of  the  very  few  direct  population  surveys  that  exist  (cf.  (3d1,  (331,
(341,  (351),  we  estimate  that  expenditures  connected  with  traditional  medicine
do  not  exceed  CFAF  2  billion  a  year.-9-
The  other  expenditure  items  are  smallers about  CFAF 500  million  for
clandestine  private  medical  practice  (estimate  based  on (341,  t351),  about
CFAF 250  million  for  total  fees  charged  by health  units  (estimate  based  on  a
survey  of all  health  units,  cf. (191,  appended  .ables),  and  about  CFAF 300
million  for  health-related  transportation  expenses.
The  order  of magnitude  of total  health-sector  ojerating  expenditures
for 1986  would  be as follows  (cf.  comparative  figures  in E361  to  assess  the
magnitude  of the  recent  revisions  in  relation  to the  first  effort  of this





(national  budget  +  regional  budgets)  4,200
Other  public  sources  90
Development  operations  8
INPS  380  4,678
Family  budgets
Fees  236
Modern  drugs  12,000
Traditional  medicine  2,000
Clandestine  private  fees  500
Health-related  transportation  300  15,036
External  aid  542
Total  20,256
Families  thus  now bear three  fourths  of  health  expenditure-an
expenditure  that  probably  average  CFAF 2,700  per  capita  per  year.  Free  health
care is  nothing  but  a fiction.
It  must  also  be borne in  mind that  current  per  capita  health
expenditure  is  low.  The  comparable  amount  was  already  CFAF  4,000  in  Senegal
in 1980  (according  to [371  p. 162)  but only  CFAF 2,200  in  Burkina  Faso  in 1981
(cf. [391  p. 17,  rather  than (401  p. 18,  since  the  latter  document  was
obviously  quickly  outdated,  at least  on this  point).
It  follows  that  the  problems  of health  financing  were clearly
evident  from  the  beginning  of the 1980s.  T'  was  precisely  at that time  that  a
ten-year  social  and  health  development  plai.  sor  Mali  was drawn  up.  But  while
this  document  bluntly  makes  no bones  about  the  inability  of the  government  to
assume  health  financing  (cf. (381  p. 32),  it  adopts  a typical  attitud:  first
of all,  it cites  the  possibility  that  wider  disseminatlon  of health  care  among
the  population  would  afford  in opportunity  to  get  patients  to share  in  its
financing  (cf. (381  pp.  32-33);  further  on,  however,  it claims  that,  already,
health  care  beneficiaries  have  become  accustomed  to  and  have faced  up to  the
fact  that they  must  to bear the  bulk of personal  health  expenditure  ([381  p.
157).  Wonderful! The  problem  has disappeared  without  anybody  having  had to
decide  anything  at all!  And  not %  word,  in this  same  ten-year  plan,  not  even- 10  -
in  discussing  strategies  ((381  pp.  53-55),  about  the  reasons  why it  was
ag-eed,  at the  same  time,  at the  highest  levels  of the  party,  to  examine  the
"problems  cf the  practice  of private  medicine"  ((41]  p. 18).  It is true  that
at the  same  time  the  international  organizations  fully  shared  the  national
illusions  concerning  the  feasibility  of carrying  out  simultaneously  the
ambitious  classical  program  defined  in the  1960s  and  a no loss  enormois
primary  health  care  program  (cf.  (421).
2.  New Financing  Sources?
It  will have taken  several  years,  during  which  the  health  services
have  centinued  to  deteriorate,  for  effective  account  to  be taken  of the
difficulties  perceived  from the  beginning  of the  decade. Concerning  financing
in the  true  sense,  it is  only during  the  last  few  months  that  a  number  of
alternatives  have  been put forward  and  discussed,  either  within  the  Mali
administration  (cf,  in  particular  (431  and (44])  or in the international
agencies. They concern  in particular  what  is designated  cost  recovery  (or  for
the  national  hospitals,  an obvious  abuse  of language,  management  autonomy),
sickness  insurance  and  mutual  schemes,  and  privatization  of exercise  of the
health  professions. It is  appropriate  to  consider  the  practical  --ue of each
of these  suggestions.
2.1  Cost  recovery
Decree  No. 243/PG.RM  of September  !9,  1983  laid  down  "the  system  of
remuneration  for  medical  care,  hospitalization  and  other  services  of health
units,"  accompanied  however  by very  extensive  provisions  concerning  free
health  care (for  certain  health  conditions,  students  and pupils,  health
personnQl,  the  very poor,  etc.). The  enabling  regulations,  which  were issued
a few  months  later  (Interministerial  Order  No. 1943/MF.MSPAS  of April  16,
1984)  are  a masterpiece  of ambiguity: in  Article  2 it  excludes  all  health
centers  from the  field  of application  of the  decree  while  providing  that  the
health  center  management  boards  can  implement  "various  forms  of community
participation,"  i.e.  "fees  that  may in  no case  exceed  those  prescribed  in the
decree"  mentioned  above,  with the  further  understanding  (article  22)  that
"free  care is  retained  in the  clinics  in the  context  of primary  health  care."
The  conditions  were thus  laid  down  for total  anarchy,  and  in fact  at
the  beginning  of 1988 the  Ministry  of  Health  absolutely  did  not  know  which
health  centers  charged  for  their  services,  which  services  had to  be paid  for
and  at what  price,  what  was the  amount  of revenue  and  how it  was  used.  In
this  situation  it  obviously  impossible  for  the  health  policy  authorities  to
engage  in  any  enlightened  thinking  on the  problem  of cost  recovery. The
surveys  we organized  enabled  us to  show  that:
- More than  half the cercle  health  centers  charge  for  at least  some
of their  services;  the  charges  vary  widely  but  are  always  much
higner  than  could  have  been  expected,  particularly  for  surgical
interventions  (see  the  appended  table). The  receipts  so collected
are  managed  in such a  way that  only  one  chief  physician  out  of two
among  those  that  apply  cost-recovery  has  been  able to  recoup  the
annual  amount  for  the  last  three  years;  and  no cercle  chief
physician  can  state  with  assurance  what the  situation  is in  the
arrondlsaument  health  centers  of his  district  (for  which  he is
responsible!).- II  -
- In  the  arrondissement  health  centers  that  levy  charges  (contacts
and  confinements),  the  few  cases  that  could  be studied  show  that
receipts  just  barely  cover  the  most  basic  operating  expenditures
(firewood  or oil,  surgical  spirits,  cotton  wool,  ballpoint  pens,
etc.). I  the  health  centers  that  do surgery,  the  charges  for
surgical  interventions  are  usually  the  preferred  method  of  meeting
the  operating  expenditures  of the  entire  health  unit;  in a secondary
hospital,  in contrast,  strict  application  of the  scale  of fees  laid
down  by Decree  No.  243  can  by itself  generate  sufficient  receipts  to
finance  its  entire  its  operating  expenditures  plus  the  cost  of
laboratory  supplies  (cf.  [231  pp.  149-153).
- The  amounts  recouped  by the  national  hospitals  account  for  by far
the  greater  part  of the  offic,.al  contribution  by patients  but  only a
small  fraction  of the  hospitals'  operating  expenditures,  excluding
wages. Thus,  cost  recovery  alters  the  situation  created  by the
public  budget  allocations  (cf.  [23]  p. 148)  only  very  slightly;
tota:  cost  recovery  receipts  for  the  entire  country  do  not  exceed
CFAF 250  million.
Since  this  amount  is,  properly  speaking,  negligible  in relation  to
the  health  sector's  financing  needs,  cost  recovery  does  not  offer  a solution
to the  problem  under  current  conditions.  Moreover,  it appears  to  be extremely
difficult  to  change  these  conditions  in  such  a way  that  cost  recovery  receipts
represent  a significant  proportion  of  actual  expenditure.  That  would  in fact
call  for  complete  overhaul  of each  of the  following  areas:
- Fees:  No one is in a position  to say  what is today  the  level  of
fees  which,  given  a clear  improvement  in service  quality,  the
population  would  be objectively  able  to  bear.  It is  however  known
that  the  fees  charged  outside  Bamako  are in  fact  borne  very  well
while  at the  same time  some  people,  without  saying  exactly  why,
assert  that these  fees  could  not  be applied  in Bamako  itself.
- Definition  of free  servicea: The  advantages  granted  to pupils  and
students,  social  and  health  personnel  and their  families,  civil
servants,  government-  or private-sector  employees  and  their  families
are  in practice  supplemental  benefits  enjoyed  by socio-occupational
groups  that  are  already  privileged,  particularly  as regards  access
to  health  care.  The  same is  true  of free  care for  certain  health
conditions  since  only those  with  effective  access  to  health  care  can
benefit  from it.
- Application  of the  regulations: It is surprising  to note  that  the
same  rules  lead to  charge-free  proportions  that  vary  widely  from  one
establishment  to another  (at  Point  G, 50%  of hospitalization  days,
after  deducting  all psychiatry  and phthysiology  days,  are  free  of
cost,  compared  with  only 322  at the  San  hospital  (cf.  (231  pp.
138-153). It shou.d  be noted,  however,  that  the  granting  of free
care  gives  rise to payment  by the  patients  of private  compensation
to the  health  service  staff  (patients  cared  for  by the  hospital
services  but unknown  to the  admissions  office,  a system  known  at
INRSP  as "intervention"  or "third-party  payment").- 12  -
- MNan  qeent  of  the  sums  collected:  Until  January  1989  only  the  throe
national  hospitals  and  the  86gou  regional  hospital  were  authorized,
experimentally,  to  deposit  their  receipts  into  a  bank  account  and
use  them  in  accordance  with  a  quarterly  program  approved  by  the
Ministry  of  Health.  It  is  this  that  is  called  "management
autonomy."  However,  the  public  finances  crisis  is  so  serious  that
this  solution  is  likely  to  be  rescinded  at  any  time,  se  great  is  the
temptation  to  mop  up  immediately  any  fund  that  is  not  empty.  In  the
longer  term,  however,  consideration  needs  to  be  given  to  reform  on  a
completely  different  scale,  since  the  present  system  of  administr-
ative  management,  which  deprives  the  director  of  the  establishment
and  his  board  of  all  power,  has  long  ago  demonstrated  its
inefficiency.
2.2  Sickness  insurance  and  mutual  schemes
A  number  of  recent  documents  appear  to  place  great  hope  in  relieving
the  public  finances  by  developing  sickness  insurance  and  mutual  schemes  (cf.
in  particular  [431  and  E441).
The  present  system  of  social  protection  was  legally  organised  by  Law
No.  62-68  AN/RM  of  August  9,  1962. To  us8  the  specialized  vocabulary,  it
presents  some  aspects  of  labor  medicine,  some  of  work  accident  insurance  and
some  of  cash  medicine.  Thus,  the  services  offered  by  the  INPS  are:
- recruitment,  periodic  and  work-resumption  examinations,  which  form
prrt  of  the  normal  framework  of  labor  medicine;
- compensation  for  work  accidents  and  occupational  diseases;
- certain  forms  of  preventive  care  (prenatal  supervision)  and  curative
care,  for  employees  and  members  of  their  families,  provided  in  three
protection  centers  and  15  inter-enterprise  medical  centers  (CMIE),
where  a few  drugs  should  also  be  available.
The  employees  affiliated  to  the  INPS  belong  either  to  the  public
sector  (without  being  government  employees--civil  service,  army)  or  the
private  sector.  The  number  of  card-holding  members  is  said  to  be  about
60,000,  and  the  INPS  claims  that  the  number  of  beneficiaries  is  about
250,000.  In  judging  the  reliability  of  these  figures  it  has  to  be  borne  in
mind  that  the  contributions  are  paid  by  the  employers  on  the  basis  of  total
wage  bill,  without  the  employees  being  listed  by  name;  it  is  then  up  to  the
employees  to  comply  with  the  necessary  formalities  to  obtain  a card  entitling
them  to  receive  the  services.
However,  the  number  of  wage  earning  jobs  is  still  very  low  in  Mali:
it  appears  to  be  about  150,000  at  this  time  ([451  p.  13),  including  48,000  in
the  public  sector  (34,000  civil  servants  and  14,000  other  public-sector  wage
earners,  following  a 252  reduction,  between  1979  and  1985,  in  the  staff  of  the
public  companies  and  enterprises).  It  is  immediately  apparent  that  sickness
insurance  could  affect  a  maximum  of 100,000  wage  earners,  giving  a  total  of
500,000  beneficiaries  and  eligible  persons.  This  suggests  that  the  current
number  of  insured  employees  and  beneficiaries  could  be  doubled  by  simply- 13  -
applying  the  curtent  regulations.  But  even  if  that  happened  over  the  next  few
years,  sickness  insurance  would  still  cover  barely  more  than  6S  of  Mali'f
population.
Moreover,  it  need  hardly  be  said,  no  one  can  recommend  the
establishment  of  a  system  for  farmers  without  this  suggesting  some  ulterior
motiveo  the  difficulties  encountered  in  managing  such  schemes  in  all  the
countries  that  have  tried  the  experiment  must  condemn  this  ideat  out  of  hand
unless  it  is  intended,  under  this  title,  to  create  a  new  tax  on  the  farmers.
The  question  also  arises  of  whether  the  INPS  is  in  fact  capable  of
assuming  part  of  health  expenditures,  that  of  wage-earners.  It  is  known  that
in  the  current  situation  the  INPS's  administrative  costs  absorb  nearly  half  of
its  receipts  ((461).  The  situation  is  probably  even  worse  under  the  sickness
insurance  scheme:  for  each  franc  of  health  expenditure  we  would  have  to
reckon  on  more  than  3  francs  for  fixed  assets,  administrative  charges,
depreciation  and  miscellaneous  expenses  ((47]).  It  would  be  necessary  also  to
ascertain  what  part  of  the  last  fourth  is  absorbed  not  by  the  insurees  but  by
INPS  personnel.  The  management  of  the  institution  is  such  that  it  is
impossible  to  determine  this  with  any  certainty.  However,  as  regards
pharmaceutical  products,  which  represent  annual  expenditure  of  the  order  of
CFAF  100  million  in  recent  years  (down  substantially  from  previous  years),
purchases  from  the  Bamako  PPM  against  prescriptions  issued  to  INPS  personnel
total  somewhere  between  CFAF  60  and  75  million.  The  main  activity  on  behalf
of  insurees  is thus  limited  to consultations:  during  recent  years  the INPS
claims  to  have  recorded,  for  the  whole  of  the  CMIEs  and  enterprise  clinics,
about  200,000  episodes  and  4-500,000  contacts  a  year. But  since  the  quality
of  these  statistics  is  just  as  poor  at  the  INPS  as  in  the  public  health  units,
only  the  first  figure  may  have  any  significance.  Moreover,  the  practical
conditions  under  which  the  activities  of  the  centers  are  conducted,
particularly  at  Bamako,  are  such  that  episodes  may  not  relate  to  wage-earners
duly  registered  with  the  INPS  or  their  eligible  beneficiaries  but  simply  to
residents  of  the  neighborhood  where  the  medical  center  is  located  or
acquaintances  of  INPS  staff.
Concerning  mutual  insurance  schemes,  an  Order  of  October  19,  1945,
as  amended  by  laws  of  April  27  and  August  23,  1947,  is  still  in  force,  but  has
fallen  into  disuse.  For  example,  when  the  National  Education  and  Culture
Union  (SNEC--Syndlcat  National  de  1'Education  et  de  Is  Culture)  decided  in
1986  to  establish  a  mutual  or  friendly  society  with  the  object  of  setting  up  a
supplementary  system  covering  retirement  and  all  solidarity  and  mutual
assistance  activities,  the  acknowledgment  of  its  official  declaration  to  the
administration  referred  to  Order  No.  41/PGG  of  March  28,  1959  "relating  to
associations  (other  than  commercial  companies,  mutual  assistance  companies,
cultural  associations  and  congregations)."
One  can  imagine  the  mutuals  system  developing,  as  it  has  in  the
western  countries,  first  of  all  in  certain  relatively  qualified  occupational
groups  that  exhibit  a certain  social  solidarity.  These  would  probably  not
consist  of  skilled  workers,  who  are  still  much  too  few,  but  perhaps  of  civil
servants  or  employees  of  the  large  public-sector  enterprises.  As  we  saw
earlier,  the  number  of  people  in  these  categories  does  not  exceed  50,000;- 14  _
thus,  even  if important  initiatives  were  taken  to promote  mutual  insurance,
its  coverage  would  not  exceed  250,000  beneficiaries  in the  next  few  years.
All  this  shows  clearly  that  the  problem  of financing  the  health
services  will  not  be resolved  through  sickness  insurance  or mutual  schemes,  as
some  people--particularly  the  representatives  of the  medical  orders
(481--appear  to  believe. While  the  development  of institutions  of this  kind
is  entirely  desirable,  they  affect  access  to  health  care  for  only  a small
number  of people  and then  only in the  capital  city.  In  these  circumstances
neither  sickness  insurance  nor  mutual  schemes  offer  possible  solutions
commensurate  with the  problem  to  be resolved,  a problem  the  concerns  first  of
all the  rural  population.
2.3  Private  exercise  of the  health  professions
The  regulations  authorizing  private  exercise  of the  health
professions  were  published  in 1985  (Law  No.  85-41/AN.RM  and its  enabling
regulations).  These  legislative  instruments  concern  doctors,  dental  surgeons
and  midwives,  who may  henceforth  open  professional  offices  or clinics,  and
also  dispensary  pharmacists. What is  the  relevance  of these  documents  to the
creation  of new  sources  of financing  of  health  expenditures?
As regards  the  distribution  of pharmaceutical  products,  no one
claims  that  investment  is the  main  problem. The  Mali People's  Pharmacy  (PPM)
possesses  an adequate  number  (about  100)  of dispensaries  and  depots  (cf.  (491
pp.  2-3).  It is  of course  conceivable  that  it could  sell  them  to raise
resources  or meet the  wishes  of the  pharmacists  (cf.  (501  p. 3),  but  an
adequate  network  exists  and the  PPM  has  never  lacked  external  aid  to replenish
its  internal  funds.
Thus,  for  privatization  of drug  distribution  to  be effective  in
relieving  the  public  finances,  the  cost  of drugs  to the  users (not  least  among
which,  however,  is the  government,  as we saw  earlier)  would  need to  be reduced
below  the  present  levels. For  that  to  be  possible,  either  margins  would  have
to  be lower  in the  private  enterprises  than  in the  public  company  or
procurement  prices  would  have to  be lower.
Regarding  purchase  prices,  it  is  not  clear  what  the  advocates  of
privatization  hope for:  if  the import  monopoly  continues,  the  PPM  is  already
in the  best  situation  to purchase  through  calls  for  bids  on the  world  market
because  it  has  the  largest  order  volume;  and if it  does  not  do so because  its
own funds  are  inadequate,  the  amounts  involved  are  clearly  out of proportion
with  what it  could  raise  through  private  participation  in its  capital. If the
import  monopoly  is  abolished,  the  importers,  by dividing  their  order  volume,
will  obviously  only  obtain  higher  prices.
Turning  to  margins,  those  of the  PPM  are  known.  The  gross  margin
(difference  between  turnover  and cost  price  of sales,  as a percentage  of
turnover)  was 22S  in 1980  (according  to [511  p. 15),  262  in  1986  and  252  in
1987 ([521  p. 3),  and since  1982  has  not  fallen  appreciably  below  that  level
except  in  1984  and 1985 (E521  p. 46). The  margin  was to  be raised  to  32%
under  a new  price  scale  to  be adopted  in  1988,  and  a  new scale  was in  fact
published  in  August  of that  year.  However,  on December  13,  1988  a new
Interministerial  Order,  No. 5024,  provided  that  all  drugs  would  henceforth  be- 15  -
sold  in  Mali  at a price  obtained  by  applying  a multiplier  of 1.95  to their
price  c.i.f/Bamako  (compared  with  previous  factors  of 1.4  for  essential  drugs
and  2.06  for  other  drugs)  and that  the  margin  of private  dispensaries  would  be
25.52'  of the  public  sale  price. It is thus  clear  that,  for  the  conditions
under  which  it  is  organized  in  Mali,  privatization  is just  as expensive  as a
particularly  badly  managed  public  company  was.
Concerning  exercise  of the  health  professions  proper,  the  Mali
regulations  simply  transpose  the  situation  in  France,  whereas  a number  of
adaptations  might  have  been  wise. For  example,  one  cannot  help  wondering  what
the  purpose  is  of setting  charges  for  medical  services  by interministerial
order. It is  explained  neither  by the  existence  of a general  sickness
insurance  scheme  whose  financial  equilibrium  needs  to  be protected  nor, having
regard  to  Mali's  current  economic  policies,  by a general  context  of price
control.
From the  standpoint  of  our  concerns  in the  present  document,  the
only  question  is  whether  these  regulations  can  henceforth  cause  a significant
portion  of the  health  care  demand  currently  met  by the  public  sector  to be
attracted  away  by the  private  sector. The level  at which  it  has  been  decided
to  set  these  charges  (for  example,  CFAF  4,185  for  consultation  of a general
practitioner  and  CFAF 18,600  per  day  of first-grade  hospitalization  in  a
private  clinic)  shows  clearly  that  the  purpose  of intervention  by the
administration  has  not  been to  guarantee  access  to care  by private
practitioners  by the  ordinary  run  of the  people. To illustrate  this  point  we
may  add that  in  Mali the  fee  for  consulting  a general  practitioner  represents
about  8% of GNP per  capita  (which  is  about  CFAF 54,000)  whereas  the  charge
applied  in  France,  where  more than  901  of the  population  is  covered  by a
sickness  insurance  scheme,  represents  only  about  2  per  mill  of GNP (about  FF
120  out  of FF 65.000). The question  therefore  becomes  the  following: what
proportion  of Mali's  population  will  agree  to receive  care  at this  price  in
Mali?  It  will certainly-not  include  civil  servants,  having  regard  to their
average  income  level  and the  fall  in their  purchasing  power  (251  between  1980
and  1986,  according  to [531  pp.  10  and 28).  It  can  only concern  the  "well-off
segments  of the  population  (...  ),  businessmen,  industrialists,  members  of the
liberal  professions"  ([431  pp.  20-21),  and then  provided  that  they  neither
have  relatives  in the  public  sector  nor  are  able to obtain  care  abroad.
More generally,  detailed  and  unrealistic  regulation  of private
practice  by health  professionals  and  of the  scales  of fees  for  their  services
strengthens  private  practice  for  those  who  already  have  a clientele  and
compromises  experimentation  by  other  with (and  possibly  the  dissemination  of)
formulas  tailored  to  varying  local  or socio-occupational  contexts. However,
particular  reference  is  made in  some  circles  to such  forms  of  medical  practice
as rural  doctor  (l541)  and  salaried  doctor  practising  in  a health  unit  managed
by a local  community,  a mutual  society  or a neighborhood  association  ((551).
One  can  easily  imagine  such forms  of  medical  practice  being  suited  to
unemployed  young  Medical  School  graduates  and  at the  same  time  to fairly  large
population  groups,  but  no provision  is  made for them  in the  ingenuously
Malthusian  legislation  introduced  since  1985.- 16  -
2.4  Limitations  of these  proposals
The  foregoing  demonstrates  clearly  that  the  new sources  of financing
to  which  reference  has  recently  begun  to  be made  are  not,  at least  in the  case
of Mali,  commensurate  with the  problem  to  be resolved. The  same  applies  to
external  aid.
The  important  place  of aid in some  estimates  of financial  flows
allocated  to  health  (for  example  (361)  is  due  in  part to  accounting
conventions:  while  it is  clearly  perfectly  legitimate  to value  technical
assistance  on the  basis  of its  actual  cost to  the  country  or the  organization
paying  for  it,  it  does  not  make  a lot  of sense  to  augment  the  amounts  so
obtained,  particularly  those  for  operating  expenditures,  by the  costs  borne  by
the  administration  of the  country  assisted  or  by its  population. The
estimates  are then  artificially  swollen  by substantial  expenditures-having
regard  particularly  to the  discrepancy  between  national  and  expatriates
salaries--effected  outside  the  country  assisted,  over  which  the  latter  has  no
control  and the  real  counterpart  to  which  (in  the  form  of health  services  to
the  population)  may  be extremely  low.
If  we stick  with  a more  prudent  estimate,  we find  that  aid is
decisive  in the  case  of investment  but  makes  only  a small  contribution  to
operational  financing  (cf.  (191). It  goes  without  saying,  and every  one is  no
doubt  aware  of this,  that  there  is a political  limit  on the  share  that
external  aid can  represent  in the  financing  of recurrent  costs:  independence
becomes  a fiction  that  is increasingly  difficult  to sustain. But intolerable
recurrent  charges  can  be created  by poorly  thought-out  investment  decisions:
the  very recent  example  of the  construction  of  a seriously  over-dimensioned
hospital  at Timbuktu  (CFAF  3  billion  for  84  beds,  apparently,  cf. [571)
clearly  illustrates  this  danger;  yet the  possibility  is  under  consideration,
at the  pressing  initiative  of the  African  Development  Bank,  of repeating  the
exercise  at Niafunk6,  Dir6  and perhaps  even  elsewhere!
All this  serves  to demonstrate  the  limits,  even  the  dangers,  of
solutions  based  only  on the  use  of new resources. Yet  it is also  quite  clear
that,  under  the  influence  of the  international  organizations,  which  are
unanimous  on this  point,  a blinkered  view  of the  problem  has  been taken  so
far: efforts  are  focused  on finding  new  resources  without  consideration  of
whether,  by any  chance,  costs  could  not--ought  not?-to be appreciably
reduced.
3.  Trimming  monumental  waste?
The  estimate  of  annual  volume  of operating  expenditures  proposed
above  shows  that  two  items  are  of prime  importance:  purchases  of
pharmaceuticals  (order  of  magnitude: CFAF  6 billion  according  to PPM turnover
alone  and at least  double  that  for  aggregate  pharmaceuticals  consumption),  and
personnel  expenditures  (order  of  magnitude: CFAF  3  billion,  cf. (191,
appended  tables). As all  observers  are  aware,  the  possibility  of reducing
these  costs  is plain  to see; :he  main questions  that  arise  are the  size  of  the
expected  benefit  and  how long it  would  take  to implement  the  desired  changes.- 17  -
3.1  Staff
Personnel  coats  are  obtained  by  multiplying  swollen  and  poorly
distributed  staffs  by  miserable  salaries.  Although  few  studies  have  been  done
on  this  sensitive  point,  the  low  productivity  of  health  service  personnel  can
be illustrated  by  many  examples.  Thus,  in  regions  6  and  7,  a  nursing  person
is  consulted  by  an  average  of  7-8  patients  per  contacts  day  (nearly  10  if  the
nurse  works  in  a  cercle  health  center,  only  6  in  an  arrondlssement  clinic)
and  a  doctor  10-Il  patients;  this  never  represents  more  than  2  hours  of  actual
work  at day  (cf.  (561  pp.  46-47).  Similar  observations  have  been  made  in
region  5  (Dr.  Brugi&re,  personal  communication)  and  in  a laboratory  in  region
I  (less  than  I  hour  of  actual  work  per  staff  member  per  day,  cf.  (581  p.  23).
This  situation  is  due  to  many  factors,  which  can  be  grouped  into  two
categories:
- First,  the  spatial  assignment  of  staff  is  based  on  personal
convenience  and  not  on  the  needs  of  the  service  (staff  mmbers
refuse  assignments  that  do  not  suit  them  and  have  positions  created
in  the  localities  where  they  wish  to  live).  As  a result,  the  staff
are  not  in  place  where  the  demand  for  services  exists.  For  example,
midwives  are  superabundant  in  the  Bamako  community  maternity  clinics
and  health  center  but  in  short  supply  in  the  corcle  health
centers.  The  control  over  the  territorial  distribution  of  medical
staff  and  services  exercised  by  the  Ministry  of  Health  at  the
beginning  of  the  l970s  had  disappeared  by  1975  (cf.  (201  pp.  89-94).
- Second,  the  poor  functioning  of  the  health  units  depresses  demand:
the  objective  lack  of  resources  is  aggravated  by  indifference  and
unconcern  (hierarchical  control  is  no  longer  exercised  and,  for
example,  staff  make  patients  reward  them  in  money  or  in  kind,  cf.
(34]  pp.  52-54)  to  bring  it  home  to  patients  that  they  are  only  a
nuisance  and  any  one  wanting  care  had  better  have  money.
With  its  present  staffing,  therefore,  the  health  system  possesses
substantial  productivity  reserves  which  could  be  mobilized  either  to  reduce
the  wage  bill  or  to  expand  activities.  But  it  is  not  clear  how  these  reserves
could  be  put  to  work: cutting  staff  beyond  freezing  recruitment  and  the
rehiring  of  people  who  leave  the  public  service  i.  politically  unthinkable;
and  expanding  activity  almost  certainly  implies  significantly  improving  the
quality  of  the  services,  which  in  turn  probably  necessitates  raising  average
salary  levels  (though  it  is  alas  to  be  feared  that  that  would  not  suffice).
For  these  reasons  it  is  unrealistic  to  assume  that  the  waste  that
currently  characterizes  personnel  management  can  be  rapidly  reduced.  In  the
following  pages,  therefore,  we  shall  confine  our  examination  to  drug
procurement.
3.2  Drugs
The  diagnosis  of  colossal  waste  in  the  area  of  drugs  dates  back  to
the  beginning  of  the  1980s  (cf.  (59]  pp.  2-4). It  has  been  known  at  least
since  then  that:- 18  -
- Prescribing  is of poor  quality: practitioners  have  acquired  shoddy
prescribing  habits  stemming  from  their  poor  diagnostic  ability,  the
practice  of symptom  treatment,  lack  of control  of prescriber
quality,  and inadequate  training  and information  (t591  p. 2).
- Drugs  management  is  deplorable.  In  particular,  the  coexistence  of
free  drugs (in  the  public  health  units,  to the  extent  that  they  are
available)  and pay  drugs  (the  balance  of consumption)  is  a "source
of trafficking"  ((591  p.  4);  the  range  of products  marketed  is  far
too  wide (more  than  2,000  specialized  products,  cf. (49]  p. 1),
which  encourages  losses,  theft  and  spoilage  (up  to 201  of cost
price, (591  p. 4); there  is  absolutely  no control  of selling  prices
((591  p. 2),  and finally,  the  PPM,  which  has  an import  monopoly
"makes  86S  of its  purchases  from  foreign  suppliers  under  the  private
contract  system"  (cf.  [49]  p. 1).
The  scale  of waste  has  never  been estimated  because  such  an
assessment  would  present  insurmountable  difficulties.  However,  fairly
plentiful  data  are  available  for  such  a purpose. They  fall  readily  into  two
categories:
- We know  the  average  cost  of a drug  prescription  given  to  an
out-patient  in a number  of health  units: a minimum  of CFAF 1,500
(and  a maximum  of CFAF  2,600)  in  the  cercle  health  centers  of
region  1 (cf. (60],  [611,  (621),  where  drugs  are  prescribed  on the
basis  of the  PPM's  available  supplies  and  at PPM  prices;  at least
CFAF 200  (and  at most  CFAF  450) in  health  centers  that  possess  a
health  shop in regions  5,  6  and 7  (cf.[  231  pp.  55-58  for  regions  6
and 7, [631  for  region  5).
- We know the  quantities  prescribed  of each product  used,  and the
corresponding  costs,  in three  cercles  of region  5 (health  shops
project  carried  out  with  the  technical  assistance  of Mddecins  du
Mond.).  We can revalue  these  quantities  at PPM  prices. We also
know  the  quantities  used  for  in-hospital  patients  and their  cost,
for  the  health  development  project  financed  by the  World  Bank  in
region  1, this  project  is  operating  without  any  change  whatever  in
the  conditions  of drug  procurement  (cf.  (231  pp.  33-40). We know,
at least  for  one  year,  the  quantities  consumed  of the  30 drugs  most
used  in the  Point  G hospital  and  their  cost  at PPM  prices;  we can
revalue  these  quantities  at health  shop  prices  after  replacing  each
specialized  product  prescribed  by the  closest  essential  drug that
would  have  been  available  in  a health  shop  but  without  otherwise
changing  the  prescription  (in  particular  the  forms  prescribed  are
respected,  cf. (231  pp.  96-100).
The  data in the  first  category  give  the  combined  effect  of selecting
drugs  and  purchasing  at best  price;  the  prescriptions  written  in the  ordinary
health  units  ignore  both of these  means  of rationalizing  drug  expenditure,
whereas  those  written  in the  units  in regions  5, 6 and 7  use  both  of them:
prescription  from  a list  of essential  drugs  with  common  international
denomination  (and  an effort  to  use injectable  drugs  only  when they  are  clearly
preferable  to  oral  administration),  and  procurement  by competitive  bidding  on- 19  -
the  international  market  (or  at least  by restricted  invitation  to tender).
According  to the  figures  quoted  above  it  can  be stated  without  exaggeration
that  prescribing  is four  times  less  expensive  under  these  conditions  than  it
is  based  on  PPM  availability  and  prices.
The  data in the  second  category  give  only the  etLect  of  price
differences:  they  show that,  for  the  products  considered,  procurement  at PPM
prices  is  at least  twice  as expensive  as procurement  at world  market  prices.
Thus,  the  value  of the  30  products  most  heavily  consumed  at Point  G at health
shop  prices  is half that  at PPM  prices;  the  value  of products  consumed  in one
of the  cereles  of the  health  development  project  at health  shop  prices  does
not  exceed  42%  of their  value  at the  prices  that  have  been paid;  and  the  value
of the  quantities  consumed  in  the  health  shops  of region  5  at PPM  prices  is
double  their  value  at the  cost  price  to the  shops.
It  follows  that  under  PPM  conditions  (preference  for  specialized
products  and  for  purchases  under  private  contracts)  drug procurement  costs
Mali  about  4 times  what it  would  have  to pay  if it  effectively  applied  its
essential  drugs  strategy  and  used  the  familiar  procedure  of international
calls  for  bids.  Product  choice  accounts  for  about  half the  difference  and
price  differentials  for the  other  half.
4.  A Realistic  Solution
In  the  following  pages  we shall  use  a simplified  representation  of
the  health  system,  both as it  now stands  and  how it  could  be if  certain
decisions  were taken  concerning  its  financing. To be able to  construct  such  a
model  we  need to  define  the  conditions  under  which  the  health  system  operates
(or  could  operate),  such  as for  example:
- what  are (or  could  be) the  main  activities  of the  system,  at the
various  levels  of its  organizational  pyramid?
- what  is (or  could  be) the  rate  of utilization  of these  various
activities?
- what  is (or  could  be) the  unit  cost  of each  of the  major  services
within  each  activity?
- what  is  (or  could  be)  the  fee  charged  for  each  of  these  services  and
therefore  the  expected  volume  of  receipts  generated  by  charging?
An extremely  simple  model  constructed  in  this  way,  on  explicit
bases,  which  can  be submitted  to  discussion  and if  necessary  modified,  gives  a
picture  of the  variation  both in the  aggregate  amount  of  financing  required
when  or the  other  condition  of operation  is  modified  and the  aggregate  amount
of the  resources  that  can  actually  be raised. The  value  of such  a table  is
that  it  allows  immediate  calculation  of the  consequences  of any  modification
of the  hypotheses  it contains.
4.1  Characteristics  of the  sLmulation  model
The  first  stage  consists  in  defining  the  activities  to  be financed
and the  costs  of each  activity. We shall  confine  ourselves  to  modern- 20  -
medicine: it is  there  that  a financing  problem  arises,  since  the  public
authorities  have  not  pursued  an active  policy  of support--which  would  involve
for  example  financial  assistance--for  traditional  medicine.
The  figures  used for  the  essential  variables  of the  model  are  not
taken  from  the  Health  Ministry's  statistical  data  system:
- first,  the  quality  of the  data  collected  is  very  mediocre;  this  is
particularly  true  of the  statistics  on  activities  and  therefore  of
average  cost  per  activity  unit;
- second,  the  observed  values  for  the  activity  and cost  variables
would  reflect  the  conditions  of  management  of the  health  system
during  recent  years  and these  conditions  cannot  serve  as an
acceptable  reference  basis  for  projection: the  budget  resource  and
personnel  allocations  are  based  on neither  the  quantitative  nor the
qualitative  level  of the  services,  and the  practical  conditions  of
supervision  are such  that  service  quality  control  is  totally
lacking;  there  is  no purpose  in  working  with the  costs  of services
whose  quality  is  neither  acceptable  nor  at least  approximately
uniform.
In  these  circumstances,  instead  of the  observed  values  for  the
entire  health  system  over recent  years,  we have  used  as our  basis  a number  of
particular  cases,  those  for  which  reliable  data  are  available  on activities
whose  quality  can  be regarded  as acceptable.  This  does  not  make the
hypotheses  used for  the  simulation  unrealistic.  Concerning  service
utilization  rates,  service  technical  levels  and  procurement  costs,  we shall
use  simulation  bases  very  close  to  the  practical  conditions  observed  in  Mali
during  recent  years. However,  the  examples  used to fix  the  orders  of
magnitude  of the  simulation  parameters  are  often,  for  a very simple
reason--the  existence  of a minimum  of  data  here  and  not  elsewhere--those  of
health  units  that  have in  one  way  or  another  received  project  aid.  For  the
same  reasons  we have  also  decided  to  describe  those  activities  and  costs  for
which  valid  data are  available  rather  than  activities  that  appear  in job  and
post  descriptions  but that  nobody  is  able to  carry  out.  The fact  that  the
technical  level  of the  activities  no  doubt  hardly  varies  at all  when  we pass
from  one  level  of the  pyramid  to  another  diminishes  the  drawbacks  stemming
from  this  constraint.
In  practice,  we disregard  activities  associated  with  confinements
that  take  place  in rural  maternity  hospitals  and arrondissement  clinics.
The  hospitalization  activities  of the  cercle  health  centers  and  those  of the
hospitals  (including  the  national  hospitals)  are  grouped  together;  while  this
procedure  may  be surprising,  it  is justified  by the  information  available  on
the  nature  of the  activities  of these  types  of establishments  (cf.  (231  pp.
77-94). Similarly,  we shall  disregard  education  and  basic  and  refresher
training  activities  for  health  staff  to  be assigned  to  villages  or  groups  of
villages,  activities  which,  despite  their  important  place  in certain  health
projects,  have  never  been  shown  to  have  an impact--beyond  their  start-up
phase--on  either  the  level  or the  quality  of the  services  (cf.  [231  pp.
1-18). We shall  also  disregard  nutritional  and social  activities: the  former- 21 -
relate  essentially  to  emergency  programs  supported  by special  financing;  and
the  latter  can  be regarded,  considering  the  present  htalth  situation  of the
country  as a whole  and  their  geographical  location,  as luxury  or at the  very
least  premature  programs. Finally,  account  is  not taken  of vertical  programs
because,  since  they  are  in fact  favored  by certain  donors  and  certain  public
health  administrators,  financing  for  them  is  always  assured,  when the
political  authorities  so  desire,  by external  aid,  without  regard  either  to
their  efficacy  or to  the  impact  they  can  have  on the  organization  and
operation  of the  horizontal  services.
The  following  table  shows  the  orders  of  magnitude  of the  parameters
than  can  be used,  at the  various  levels  of the  health  pyramid;  it  also
specifies  the  origin  of the  information  used.
This  table  prompts  the  following  comments.
Regarding  service  utilization  rates,  those  given  for  the  cercle
towns  do indeed  relate  to the latter  (and  not to the  entire  cerc2e),  whereas
those  given  for  the  arrondissements  relate  only to  the  peripheral
arrondiss.ment  (the  central  arrondissements  being  by  definition  those  of
the  cercle  capital);  the  Bamako  district  is treated  separately. It  was
necessary  to  use these  definitions  because  of the  low  attraction  radius  of th.
health  units:  it  has  been  shown  that  the  service  utilization  rate  falls  to a
negligible  value  (less  than  one  contact  per 100  inhabitants  in a year)  when
the  distance  to the  cercle  health  center  exceeds  15  km (cf. (581). While
the  choice  of these  definitions  can  hamper  comparison  between  the  figures  used
by us and those  published  in other  studies,  we felt  it to  be clearly
preferable. Moreover,  the  extreme  diversity  in  service  utilization  rates
noted  at all levels  of the  health  system  is  due to  many  factors. These  range
from  interregional  differences  in  access  to  care  and  in the  att-itudes  of the
population  to it to  no less  important  differences  between  health  units in the
reputation,  skills  and  attitude  of the-health  personnel. This  dispersion  is
obviously  a source  of  extreme  difficulty  when it  comes  to introducing  a
particular  value  for  this  parameter  into  the  model.
Self-medication  and  private  prescribing  are  of considerable
importance  which  must  be reflected  as well as possible  in our  estimates.
Unfortunately,  this  phenomenon,  which  many people  prefer  to ignore  about,  can
be measured  only indirectly. It is  certainly  known  that,  at Niono,  20S  of
dispensary  customers  present  prescriptions  that  have  not  been issued  in  a
health  unit and  65  of  customers  purchase  without  prescription  ([651  p. 77).
Similarly,  at Bamako,  self-medication  represents  481  of purchases,  and
prescriptions  written  by "anonymous"  prescribers  (people  probably  incapable  of
obtaining  a qualification  to prescribe)  132  ([671  p. 22).  But to  be able to
estimate  the  value  of drugs  supplied  in this  way  at  each  of the  health-pyramid
levels  defined  by us,  we  had to combine  data on PPM  turnover  and  data from the
survey  of total  private  consumption.
Thus,  we had  to  obtain  from  the  PPM  an estimate  of the  turnover  of
the  pharmaceutical  depots  for  the first  half  of 1986. This  estimate  uses the
amount  of the  discounts  granted  by the  dispensaries  to the  depot  managers  and
the  rate  of these  discounts  (in  principle,  151  or 101,  depending  on the
seniority  of the  depots)  to calculate  the  value  of the  sales  effected  in this
way.  Although  approximate,  this  estimate  shows  that  sales  by the  depots  are- 22  -
of the  order  of CFAF 2  billion  a  year  in the  peripheral  arrondissements.  We
estimate  the  amount  of the  sales  corresponding  to private  practice  and
self-medication  as the  difference  between  this  figure  and our  estimate  of
consumption  of drugs  prescribed  by the  health  service  staff  in the
arrondissements  and  villages.
Moreover,  what  we know  about  official  turnover  and  actual
consumption  (cf.  above,  para.  1.3)  prompts  us to  double  the  turnover  figure.
But this  means  that  we are  estimating  globally,  without  being  able  to
distinguish  between  them,  the  consumption  pertaining  to  private  prescription
and  self-medication  and the  price  supplements  charged  by PPM  dispensary
managers.
When  we turn  to the  cercle capital  towns  and the  district  of
Bamako  the  question  is  more  difficult. We know the  turnover  of the  Bamako  PPM
but there  are several  reasons  to  believe  that  a percentage  of the  products
purchased  there  is  intended  for  sale  in the  regional  and  cercle capitals.
Moreover,  the  available  data  on prescription  and  self-medication  are
appreciably  less  fruitful  for  the  district  than  for the  rest  of the  country.
In  practice,  the  figure  assigned  to  drug  consumption  corresponding  to
self-medication  and  private  prescription  for  the  cercle  capitals  relates  to
all  of the  latter  plus  Bamako.
Regarding  unit  costs,  the  table  shows  all the  available  data
according  to the  case  studies  but  does  not bring  out  a point  which  will  be of
prime  importance  when it  comes  to  selecting  the  level  of unit  costs  to  be used
in the  simulation.
The  unit  costs  attained  by the  health  shops  in regions  6  and 7,
designated  in table  l  by (MSF),  derive  both from  purchases  at particularly  low
prices  and  low  charges. The latter  are limited  to transportation  and
insurance  costs  from  Europe  and  within  Mali  and certain  storage-expenses.  In
total,  the  estimated  amount  of supplies  delivered  to destination  (in  the
cereles  and  arrondissements)  is  about  1.7  times  the  f.o.b.  value  of
purchases  from  suppliers;  the  value  c.i.f.lBamako  is  about  1.3 times  the
f.o.b.  value,  and  the  value  at destination  1.288  times  the  value  c.i.f./Bamako
(cf.  (56],  Annex  A).  The  charges  incorporated  in the  value  at destination  are
the  expenses  of bid calls,  storage  and  administrative  supplies  and
transportation  between  Bamako  and the  destination  localities.
Rather  than  going  into  the  details  of the  calculations--though  this
could  be useful  for the  purposes  of more  thorough  study--we  point  out  only
that  they  do not  take  account  of distribution  expenses  proper. The  reason  is
that  the  system  is nanaged  essentially  by the  public  health  personnel.
Experience  shows  that  these  operating  conditions  cannot  be generalized,  for
two  basic  reasons:
- they  do not  allow  an acceptable  rate  of drug cost  recovery: the
rate  does  not  exceed  22%  (cf. (56]  p. 31)  and this  poor  result  is
attributable  to the  behavior  of the  public  health  personnel  (cf.
(561  pp. 27,  30,  37);
- consequently,  they  are  too  heavily  geared  to external  aid.- 23  -
The  unit  costa  attained  by the  health  shops  set  up by M6decins  du
Monde,  designated  in table  1  by (MDM)  derive  from  purchases  at prices  fairly
comparable  to those  obtained  by MSF  plus  fuller  incorporation  of distribution
costs. rn total,  the  selling  price  of drugs  is  obtained  by multiplying  the
price  paid to the  supplier  by 2.5. This  allows  financing  from  drug  sales  not
only  of consumables  and  small  equipment  required  to  administer  treatments  but
not  sold  but  also  of distribution  expenses  (salaries  and travel  expenses  for
one  manager  per  arrondissement) and  part  of the  supervision  expenses  and
operating  costs  of the  health  units. The  modalities  chosen  permitted  a
recovery  rate  close  to 1002  in the  two  cercles of Bankass  and  Koro,  where
however  the  activity  of the  health  services  is  not  exceptionally  great.
For  these  reasons  the  unit  costs  of the  Medecins du Monde  health
shops  will  provide  the  basis  for  our  simulations.- 24  -
Table  1
ORDER  OF  MAGNITUDE  OF MODEL  PARAMETERS
Activity  parameter  Order  of  magnitude  Notes  Reference
Total  population  7,600,000  1987  General  Census  (661
Rural  population  (RP)  5,300,000  1987  General  Census  1663
Urban  population  outside  BKO (UP)  1,600.000  1987  General  Census  1661
Oistrict  population  (PB)  700.000  1987  General  Census  [66]
Village  or  section
HS and  AS utilization  25%  of  RP  Djidian  (AFVP)  1983: 6-10%  r23]  pp.  7-l1
Bankass  and  Koro  (MOM): _3-40%  123]  pp. 1-5
Kolokani  (1986):  24%  [23]  pp. 11-15
Orugs/inhab.  CFAF  30-230  (PPM)  Kita,  Bafoulabe,  Kenieba  (PDS)  1985: CFAF  30-50  [231  pp. 19  ff.
Bjidian  (AFVP)  1983:  from  CFAF  83 to  230  (231  pp. 7-11
Kolokani  (1986): from  CFAF  34  to 118  [23]  pp. 11-15
CFAF  15  (NS)  Bankass  and  Koro  (MOM): 15  CFAF  (23]  pp. 1-5
Arrondissements
Utilization
with  no change  10%  of  RP  Djidian  (AFVP)  1983-86: 9-13%  [23]  pp.  7-P
Nossombougou  1985-87:  8%  [231  pp. 160
existence  of  drugs  12-30%  of  RP  Bankass  (MOM)  1987: 31%  123]  pp. 1-5
Koro  (MOM)  1987: 12%  [23]  pp. 1-5
Timbuktu  Region  (NSF)  1987: 13%  [23]  pp.  43 ff.
Gao Region  (NSF)  1987: 17%  [231  pp.  43 ff.
Proscription  per  episode  CFAF  1.000  (PPM)  Nossombougou  1985-87:  CFAF  960  [23]  pp. 160
Niono  1988: CFAF  2,600  (to  be  checked)  !b5l
CFAF  400 (MS)  Bankass  (MOM)  1987: CFAF  364  [23]  pp. 1-5
Koro  (KiM)  1987: CFAF  416  [23]  pp. 1-5
Timbuktu  Region  (MSF)  1987: CfAF  225  (23]  pp.  43  ff.
Gao  Region  (NSF)  1987: CFAF  282  (231  pp.  43 ff.
Private  prescription  and self-medicn.  CfAF  800/inhab.  (PPM)  Estimation  by  difference  (see  text)
LRIe capita
Utilization
wit;h  no  change  6-30%  of  UP  Kolokani  1985-86:  6% (under-recording)  1231  pp. 11-15
Kita  attraction  zone  (PUS)  1987: 30%  (58]
Mahina  attraction  zone  (PUS)  1987: 40%  [58]
Bafoulab&  attraction  zone  (PDS)  1987: 307  (58]
Kdnieba  attraction  zone  (P0S)  1987:  317  [58]- 25  -
Existence  of  drugs  20-100Z  of  UP  Bankass  (I)HO)  1987:  52X  [231  pp. I-5
Koro  (IIN)  1987:  20%  [23)  pp.  1-5
Timbuktu  (NSF)  1987: 29%  [23)  pp.  51-52
Goundam  (NSf)  1987:  24%  123)  pp.  51-52
Dire  (NSf)  1987:  40X  (231  pp.  Sl-52
Niafunko  (HSF)  1987:  29%  [23)  pp.  51-52
Gourma-Rharous  (ISF)  1987:  48%  (231  pp.  51-52
Gao  (NSF)  1987:  53X  1231  pp.  51-52
Bouret  ("SF)  1987:  45X  (231  pp.  51-52
lenaka  (NSF)  1987:  55X  [23]  pp 51-52
Ansongo  (HSF)  1987:  26%  [23)  pp.  51-52
Kidal  (NSF)  1987:  947.  (23]  pp.  S3-52
Timbuktu  Region  (NSF)  1987: 33%  (23]  ppo  51-52
Giao  Region  (NSF)  1987:  50X  1231  pp.,  51-52
Prescription  per  episode  CFAF  2.000-2,500  (PPN)  Niono  (1988):  CfAf  2.600  (651
Kita  (1985):  CFAF  1.888  1601
Kita  (1987):  CfAf  2.607  f611
Kenieba  (3986):  CAFA  2.323  1621
CfAf  200480  (NS)  Timbuktu  (NSF)  1987:  CFAF  204  (231  pp.  55-59
Ga.  (NSF)  1987:  CfAF  251  1231  pp.  55-59
Bankass  (NON)  1987:  CFAF  367  1231  pp.  '-5
Koro  (NDO)  1987:  CFAF  581  [231  pp.  I-5
Private  prescription  and  self-medicso.  CfAF  2,800/inbab.  (PPN)  Estimation  by  difterence  'see  text)
DisLtri
Utilization
no  change  #  60X  of  PB  Education  and  culture  staff  [351
increase  75%  of  P8
Proportion  of  pay  consultations  36Z  Education  and  culture  staff  [35]
Average  price  of  consultation  CFAf  1.600  Education  and  culture  staff  (35)
Druqgs
Proportion  of  buyers  601  Education  and  culture  staff  [351
Average  cost  CfAF  5I000  (PPH)  Education  and  culture  staff  [35)
CFAE  3.250  (HS)
Utilization  2-3  oJoo  of  RP  Official  statistics:  0.25X
(cercles  without  a  hospital)  (19]
Didieni  Oioila.  Kangaba:  1-3  0/oo  [341
1.13  of  UP  Official  statistics:  1.11
(cercles  with  a  hospital)  9)
2.41  of  PO  Official  statistics:  2.3%
Education  and  culture  staff:  2.4Z  1351
Existence  of  drugs  S o/oo  of  RP
3A  of  UP
3X  of  PB
Drugs  CrAf 20,000  (PPN)/admissn.  Point  6:  from  CfAF  13.000  (medicine)  to  (231  pp.  95  ff.
20.000  (surgery  gynecology)  (231  pp.378489
Point  6: beh_en"CfAF  14.000  and  37.000  [b41
CtAf  7.000  (NS)/admission  Nopti  (MON)  1987: CFAF  4,500  in  medicine
CFAF  10.000  in  surgery  (23)  pp.  95  ff.- 26  -
Utilization  0.5-4  per  admission  San (EMI)  1987: 0.5  (231  pp. 123  ff.
Nopti  (MDI)  1987: 4  [231  pp. 123  ff.
Point  G (1987): 3.5  [641
0.08-0.2  per  episode  San  (ECI)  1987: 0.08  1231  pp. 123  ff.
Mopti  (MDI)  1987: 0.2  1231  pp. 123  ff.
Cost  CFAF  200  San (ECI)  1987: CFAF  200  [231  pp. 123  ff.
Mopti  (MDM)  1987: CFAF  175  [231  pp. 123  ff.
Ka:  (PPM): at Pharsacie  Populaire  du  Mali  price
(MK):  at  health  shops  price
RP:  Rural  population  (outside  Bamako  and  cercle  uapitals)
UP:  Population  of  cercle  capitals
Pe:  Population  of  Bamako
IISF:  Midecins  sans  frontieres.  Belgium
"OM:  MI2decins  du londe
AFVP:  Association  franSaise  des  volontaires  du  progres
PDS:  Health  Development  Project  (World  Bank)
EMI:  Entrnaide  modicale  internationale- 27  -
4.2  Five  variants
Using  values  compatible  with  the  observations  presented  above  (table
I)  for  all  parameters  contained  in  the  model,  we  first  of  all  construct  a
variant  corresponding  as  closely  as  possible  to  current  activity  and  cost
levels.  To  that  end  we  select  for  the  activity  paramnters  those  shown,  in  the
upper  part  of  table  2,  under  the  heading  CURRENT  RATE  and  for  costs  those
shown  in  the  column  PPM  COST".  The  results  are  shown  further  down  in  the
table,  under  the  headings  TOTAL  COST  and  FINANCING  (column  CURRENT  ACTIVITY,
PPM  PRICES).
Three  other  variants  are  presented  in  table  2.  In  one  of  them,  the
current  activity  rates  are  retained  but  entire  pharmaceuticals  consumption  is
revalued  at  health  shop  prices  (column  CURRENT  ACTIVITY,  MS  PRICES).  In  the
other,  the  current  activity  rates  are  combined  with  procurement  at  health  shop
prices  for  products  prescribed  in  the  public  health  units  and  at  PPM  prices
for  self-medication  and  private  prescription  (column  CURRENT  ACTIVITY,  MS
PRICES  AND  PRIVATE  SECTOR).  The  third  variant  takes  into  account  the  probable
impact  of  drug  procurement  at  health  shop  prices  on  utilization  of  health  unit
services  (column  ENRANCED  ACTIVITY,  MS  PRICES).
The  first  variant  again  finds  total  health  expenditure  of  the  order
of  CFAF  17  billion  for  the  modern  sector.  This  is  consistent  with  our
previous  accounting  estimates  (in  which  we  arrived  at  CFAF  20  billion,
including  CFAF  2  billion  for  traditional  medicine  and  several  hundred  million
for  other  items  not  taken  into  account  here).  More  than  two  thirds  of  this
total  amount  relates  to  pharmaceuticals:  the  CFAF  12  billion  paid  by  the  Mali
people,  part  of  it  abroad  (purchase  of  imported  products)  and  part  to
middlemen.
The  variant  "enhanced  activity,  MS  prices"  shows  that  it  is  possible
to  finance  a  much  higher  level  of  activity  for  a  cost  of  the  order  of  only
CFAF  10  billion  on  the  sole  condition  that  the  country's  drug  needs  are  met
under  the  health  shop  type  of  arrangement.  In  this  variant  the  level  of
activity  is  much  greater  than  it  is  now  because  the  utilization  rates  in  the
arrondissements  and  cercle  capitals  douole  and  hospitalization  rates  rise
by  251  (cf.  the  differences  between  the  columns  CURRENT  RATES  AND  ENHANCED
RATES  in  the  upper  part  of  the  table);  drugs  now  represent  only  half  of  total
health  cost,  even  though  self-medication  and  private  prescription  still
account  for  the  other  half.
One  characteristic  of  this  variant  only  appears,  however,  when  we
look  at  the  distribution  of  the  amounts  allocated  to  drugs. In  the  reference
health  shops  the  selling  price  is  calculated  by  multiplying  the  supplier  price
by  2.5. When  we  use  the  corresponding  price  structure,  given  in  the  annex
(according  to  t681  p.  79),  we immediately  note  that  this  solution  offers
another  advantage,  in  addition  to  those  already  indicated:  drug  sales  then
suffice  for  (partial)  financing  of  a  number  of  activities  essential  to  the
sound  operation  of  the  health  services.  In  that  sense  this  solution  is
comparable  to  the  one  put  forward  under  the  title  "Bamako  Initiative."- 28  -
A  final  variant  which  can  readily  be studied  with the  aid  of the
same  model  would  be based  exclusively  on cost recovery: raising  the  charges
for  health  unit  services  and  reducing  the  percentage  of free  services. This
variant  (the  results  of which  are  not reproduced  here,  for  lack  of space)
shows  that  doubling  of fees,  in conjunction  with  a  general  reduction  in  the
percentage  of patients  entitled  to free  services  (from  40 to 15S),  would
increase  cost recovery  practically  threefold  in relation  to the  current
situation  but  bring  in receipts  of only just  under  CFAF 900  million. This
solution  is is  not only  clearly  socially  unacceptable  but  moreover  would  not
contribute  the  amounts  required  to  revitalize  the  health  services.Table 
FORE5EEALE  IMPACT  OF  A PHARMACEUTICAL  POLICY
District  population  7M0.A00  Rural  population  (RP  5.300.000
Urban  population  outside  SKO  (PU)  1.600.000  Total  population  (RP  7,600,000
_UTILIZAT  ION PARAIETERS  CURNRAT  H  RATE  LINI  5  CSL  OST  NSCOST
HS and  AS  access  .25  .25  Drugs/inhab..  village  100  15
Utilization.  consult..  CSA  .10  .20  Prescr./consult.,  arrond.  1,000  400
Utilization.  consult..  CSC  .20  .40  Self-eedicn./inhab.,  RP  800  300
Utilization.consult..  District  .60  .75  Prescr./consult.  CSC  2.500  400
X  paid  consultations.  District  .36  Self-medicn./inhab..  UP  2.600  800
X drug  buyers.  District  .60  Price  private  consult.,BKO  1.600  1.600
Hospital  utilization.  RP  .002  .005  Average  prescription  cost  5.000  1,250
Hospital  utilization,  UP  .011  .030  Drug  cost/hospital.  patient  20.000  7.000
Hospital  utilization.  PS  .024  .030  Cost  of lab.  test  200
Lab  tests  per  hospitalized  patient  2
Lab  tests  per  hospitalized  patient  .10
Average  stay  1  10  Cost-free  rate  0.40  0.15
2. I10AL  COST  CURRENT  ACTIVITY  CURRENT  ACTIVITY  CURRENT  ACTIVITY  ENHANCED  ACTIVITY
PPM  PRICES  HS PRICES  MS  PRICES  AN-)
PRIVATE  SECTOR
Village  or section
Drugs/inhabitant  132.500,000  19.875.000  132,500,000  19,875.000
Arrondissemeots
Orugs  prescribed  by  health  units  530.000.000  212.000,000  212,000,000  424,000.000
Private  prescription  and  self-sedicn.  3.337,500.000  1.590,000,000  3,337,500.000  1.590.000.000
Cercle  capitals
Medications  prescribed  by  health  units  800.000,000  128,000,000  128,000.000  256.000.000
Private  prescription  and  self-oedicn.  4,200,000.000  1,280.000.000  4,200.000.000  1,280,000,000
District
Private  practice  fees  241,920,000  241.920.000  241,920,000  302,400,000
Private  prescription  and  self-oedicn.  2.100.000.000  525.000.000  756,000.000  525,000,000
Hospitalization
Cost  of  drugs  900.000,000  315,000.000  315.000,000  668,500.000
Laboratory
Cost  of tests  32,800,000  32.800,000  32.800.000  32.800.000
Current  fixed  charges
Public-sector  wages  3.000,000.000  3,000.000.000  3,000.000.000  3,000,000.000
Operating  costs  (excl.  drugs)  1.500.000.000  1  .SO0000,000  1.500.000.000  1  500000.000
TOTAL  RECURRENT  COSTS  16,774,720,000  8,644.595,00f  - 13855.720,000  9.598.575.000- 30  -
3.  fINANCIG  EE  CURRENT  ACTIVITY  CURRENT  ACTIVITY  CURRENT  ACTIVITY  EUUMNCED  ACTIVITY
SCALE  PPN PRICES  MS PRICES  NS PRICES AND  NS PRICES
COST  RECOVERY  PRIVATE  SECTOR
Consultations
Arrondissement  100  31.800,000  31,800.000  31.800.000  63,600.000
Cercle  health  center  500  96,000.000  96,000.000  96.000,000  192.000.000
District  SOO  126.000.000  126,000.000  126.000.000  157.500.000
Private  practice  (Bamako)  241.920.000  241.920.000  241.920.000  302.400,000
Laboratory  32.800.000  32.800,000  32.800.000  32.80P.000
Hospitalization
Reg.  and sec.  hospitals  250  37.460.000  37.460.000  37,460.000  111.750.000
"ational  hospitals  1.500  151,200.000  151.200,000  151,200,000  189.000.000
PAYHENT  FOR  DRUGS  12,000.000.000  4,069.875.000  9.081,000.000  4.763.375.000
OWERNMENT
Wages  3.000.000.000  3.000.000.000  3.000.000,000  3.000.000.000
Operating  costs  (excl.  drugs)  1.500.000.000  1.500.000.000  1.500.000.000  1.500.000.000
TOTAL  RECEIPTS  17.217.180,000  9.287.055,000  14.298.180.000  10,312.425.000- 31  -
Conclusion
The  estimates  contained  in  the  foregoing  table  do  not  define,  in  the
required  detail,  the  solution  to  be  recomended  to  Mali's  public  health
authorities  if  they  wish  to  act  to  deal  with  the  breakdown  in  the  activities
of  the  health  system.  They  merely  show  in  what  direction  the  solution  should
be  sought.
This  direction  has  much  in  common  with  that  outlined  by  UNICEF  under
the  title  Bamako  InLelative;  it  was  after  all  only  natural  that  one  should
be  concerned  in  Mali  to  ascertain  how  the  Bamako  Initiative  could  be  given
practical  shape  there.  What  emerges  from  our  analysis  is  that  Mali  absolutely
does  not  need  additional  grants  to  be  able  to  make  drugs  available  in  the
health  units  and  dispensaries.  Very  much  to  the  contrary,  the  experiments
conducted  in  Mali  show  clearly  that  the  best  results  are  obtained  where  aid  is
least  important.  In  the  field  with  which  we  are  concerned  here,  region  5,
assisted  by  a simple  NGO,  has  developed  a formula  that  is  practically
self-financing  and  therefore  self-perpetuating  (cf.  (231  p.  75-76).  In
regions  6  and  7,  where  external  aid  has  been  greater,  it  is  not  clear  how  the
system  in  place  can  endure  without  being  subsidized  at  the  rate  of  three
fourths  of  its  cost,  and  no  one  can  say  that  that  has  to  do  only  with  the  low
level  of  living  of  the  population  (cf.  (233  p.  59-61).  In  region  2,  the
example  of  Kolokani  shows  that  massive  and  uncoordinated  aid  generates  totally
irresponsible  behavior  patterns  and  destroys  a  decade  of  patient  effort  to
rebuild  the  health  services  (cf.  (231  p.  11-15).  Finally,  in  region  1  about
CFAF  6  billion  has  been  spent  since  1985  without  any  significant  change  having
been  brought  about  in  the  conditions  of  operation  of  the  health  system  (cf.
(23]  p.  26-42),  while  aid  on  such  a large  scale  obviously  cannot  be  extended
to  the  entire  country.
The  reason  that  Mali  does  not  need  grants  to  make  drugs  accessible
and  develop  a primary  health  care  strategy  is  that  simple  application  of  the
principles  of  the  Bamako  Initiative  concerning  procurement  of  drugs  will
simultaneously  bring  about  an  appreciable  expansion  of  health  service  activity
and  a reduction  of  nearly  CFAF  8  billion  in  the  drugs  bill. The  resulting
situation,  as  described  in  table  2,  is  based  on  completely  realistic  service
utilization  and  cost  hypotheses.  On  the  latter  point,  it  assumes  that  drugs
are  sold  at  2.5  times  the  supplier  price. It  is  noteworthy  that  this  solution
compares  very  closely  with  the  one  underlying  the  various  examples  used  by
UNICEF  to  demonstrate  the  feasibility  of  the  Bamako  Initiative:
- in  Benin,  the  price  charged  for  treatments  is  on  average  3  times  the
cost  price  of  the  corresponding  drugs;  in  practice,  however,  the
multiplier  varies  according  to  the  treatment:  for  example,  it  is
1.0  for  oral  rehydration  sachets  but  5-8  for  mebendazole  treatment
of  parasitoses;
- in  Ghana  and  Zaire,  the  price  of  the  drugs  sold  by  the  health
committees  is  calculated  so  as  to  allow  the  latter  a  profit  of  L002;
the  selling  price  is  therefore  double  the  purchase  price  (cf.  (63).- 32 -
However,  the  cost  price  referred  to  in  these  examples  is  probably
the  destination  price.  We  therefore  used  the  table  2  model  to  describe  a
variant  in  which,  in  conformity  with  the  Bamako  Initiative,  the  margin
obtained  on  drug  sales  serves  to  finance  part  of  health  service  operating
costs.  The  calculations  assume  that  the  selling  price  would  be  double  the
destination  cost  price.  According  to  the  price  structure  of  the  MDM  health
shops,  given  in  the  annex,  we  know  that  for  every  CFAF  100  paid  by  rhe
patient,  destination  price  accounts  for  CFAF  88. In  other  words,  the  new
calculation  is  based  on  a  unit  pharmaceutical  prescription  cost  that  is  no
longer  CFAF  400  but  CFAF  400  x  0.88  x 2  =  CFAF  704  for  the  CSAs  and  CSCs;
similarly,  all  the  other  figures  of  the  column  MS  UNIT  COST  in  table  2  are
multiplied  by  1.76.
According  to  our  model  this  situation  leads  to  a pharmaceuticals
bill  of  CFAF  8.3  billion  for  the  population  (the  new  version  of  table  2  is  not
reproduced  here).  This  figure  is  calculated  in  such  a  way  that  private
prescribing  and  self-medication  retain  their  current  volume,  which  is  no  doubt
exaggerated  in  that  the  current  scale  of  the  phenomenon  is  due  in  large  part
to  the  deficiencies  of  the  public  health  units. In  this  case,  however,  the
pharmaceuticals  billion  is  lower  by  about  CFAF  4  billion  than  its  current
level,  and  the  100%  margin  on  destination  cost  price  generates  more  than  CFAF
4  billion,  which  can  be  used  to  finance  certain  health-system  operating
expenditures.  If  we  assume  that  private  prescribing  and  self-medication
decline  by  one-half  due  to  elimination  of  all  the  trafficking  currently
generated  by  the  scarcity  and  high  price  of  drugs,  the  pharmaceuticals  bill
would  decline  to  about  CFAF  5.2  billion,  generating  a  margin  of  only  about
CFAF  2.5  billion.
Although  the  figures  just  quoted  are  only  orders  of  magnitude,  they
deserve  consideration  because  they  show  clearly  that  the  way  Mali's  health
system  functions  can  be  changed  completely  if  it  is  decided  to  do  s80,  i.e.  if
it  is  really  desired,  by  adopting  a  drugs  policy  in  conformity  with  the
official  statements  of  past  years.  Let  us  then  accept  that  a  margin  of  some
CFAF  2.5  billion  can  be  obtained  and  consider  some  of  the  purposes  to  which  it
could  be  applied:
- establishment  of  a  working  capital  fund  for  the  PPM,  to  enable  it  to
pay  for  an  increasing  proportion  of  its  purchases  in  cash;
- rehabilitation  of  the  health  units  and  procurement  of  small
equipment  required  for  their  operation:  the  current  allocation  for
"major  repairs",  not  more  than  CFAF  40  million  a year  could  easily,
it  seems,  be increased  tenfold;  and  the  allocation  for  "materials
and  drugs"  currently  serves  only  to  deal  with  a  few  absolute
emergencies,  usually  in  the  capital  city,  needs  that  could  be  met  by
incorporating  the  cost  of  consumables  into  the  cost  price  of  the
drugs;
- financing  of  the  day-to-day  operation  of  the  units;- 33 -
- institution  of  bonuses  for  health  service  personnel:  it  must  be
admitted  that  the  current  level  of  compensation  is  inadequate  and
encourages  trafficking.  It  must  also  be  admitted  that  the  public
finances  will  not  permit  any  significant  pay  increase  for  Mali  civil
servants  in  the  next  few  years;  on the  other  hand,  we  see  no  reason
why  specific  bonuses  cannot  be instituted,  financed  out  of  own
resources.  If  CFAF  1  b5illion  were  allocated  to  such  bonuses  they
would  represent  an  increase  of  332  in  the  current  wage  bill  and
could  offer  a  means  for  restoring  hierarchical  responsibility  and
authority,  which  have  completely  disappeared,  to  Mali's  health
system.
The  above  indications  are  adequate  for  our  purpose.  They  show
clearly  that  the  therapy  for  the  collapse  of  the  public  health  services  must
be  based  primarily  not  on  cost  recovery  but  on  cost  reduction.  The
difficulties  of  cost  recovery  are  due  in  part  to  the  fact  that  costs  are
greatly  swollen  by  private  and  public  profits  that  are  all  too  clearly  evident
to  every  one. And,  quite  obviously,  the  definition  of  poverty  conferring
entitlement  to  free  care  will  not  be  the  sawe  if  costs  remain  at  the  maximum
as  if  they  are  reduced  to  the  minimum  possible.
Thus,  it  will  be  said,  it  is  only  in  the  last  line,  as  it  were,  of
this  article  that  the  author  turns  attention  to  the  equity  consequences  of  thg
Bamako  Initiative.  We  shall  not  disagree:  we  have  neglected  this  topic
because  we  believe  that  no  situation  can  be  more  inequitable  than  the  present
one. If  there  is  no  longer  time,  at  the  point  we  have  reached  in  our
discussion,  to  argue  seriously  concerning  equity,  we  can  still  point  out  that
opponents  of  the  Bamako  Initiative,  expressing  their  views  in  a  journal
usually  serious  in  its  field  of  competence,  show  no  concern  about  it  al8:
- "Today,"  we  read  in  an  authoritative  editorial,  "socially  desirable
programs  such  as  prenatal  care,  vaccination,  pregnancy  surveillance
are  provided  free  or  charge  in  practically  all  the  African
countries"  (cf.  (691  p.  1177),  yet  we  see  nothing  of  the  kind  around
us.
- "When  the  Ministry  of  Health  unfortunately  tried  to  extend  the
system  to  the  whole  of  Senegal,  with  charges  as  at  Pikine  and  health
committees  along  the  same  lines,  this  policy  failed"  (cf.  (701  p.
162)S  however,  the  reader  will  learn  nothing  more  about  this  failure
except  for  the  need  to  take  into  account  the  diversity  of  local
situations  and  the  risk  of  ideas  that  have  proved  their  worth  in
small  projects  being  converted  into  national  policy  principles.
- "An  experiment  under  way  in  Guinea-Bissau  since  1983  suggests  that
training  more  village  health  staff  is  all  that  is  needed  to  resolve
the  remuneration  problem  because  the  individual  work  load  then
decreases  to  the  point  that  the  "volontariate"  becomes  practicable"
(cf.  (711  p.  1366),  but  these  remarkable  results  appear  to  have  been
obtained  and  published  in  the  actual  start-up  year  of  the  project.-34-
In  brief,  while  we do  not  deny  that  application  of the  Bamako
Initiative  presents  serious  difficulties,  this  was  not the  place  to  go into
them. Nor  do we deny that  any  health  strategy  presents  equity  aspects  that
deserve  serious-consideration.  But  we  assert  that  the  conditions  that  govern
access  to  health  care  and drugs  in the  poorest  countries  today  are  so contrary
to  equity,  one  wonders  why the  good-hearted  do  not  begin  there;  that  the  cost
reduction  that  implementation  of the  Bamako  Initiative  can  bring  about  cannot
fail  to diminish  the  present  enormous  inequity  by giving  the  very  poor  access
to  health  care services  that  are  no longer  delivered  to them  by financially
and  morally  bankrupt  public  health  systems;  and that,  for  this  reason  in
particular,  as well  as for  the  other  reasons  developed  at length  in  the
foregoing  pages,  priority  must  be directed  not to cost  recovery  but  fairly  and
squarely  to cost  reduction.- 35 -
Annex  1
FEES  FOR  COMMONEST  SERVICES  IN  HEALTH  CENTERS
Cercle  Consultation  Confinement  Sursery
Ansongo  300  500
Bafoulab6  100  1,750  5,000  or  10,000
Banamba  300  400  5,000
Bandiagara  400  or  750
Bankass  250  5,000
Bla  400
Bougouni  200  SOO  10,000
Boure,  300  500
Di6ma  500
Dioila  400-1,000  500  3,500-6,250
Dir6  200
Douentsa  250  2,500
Gao  300  500-2,500
Goundam  200  500
Gourma Rharous  150 or  200  500  1,500
Kadiolo  250  2,500-59000
Kangaba  300  300  5,000
Kati  300  *  750
Kayes  200  1,000  or  2,000
Kani6ba  100
Kidal  300  500
Kita  100  1,000  10,000
Kolokani  50  or  100  500  12,500
Kolondi6ba  500  5,000
Koro  1,000  5,000
Koulikoro  250-300  *  1,000  15,000
Koutiala  750  4,000
Macina  300  4,000
Menaka  300  500
Mopti  500-1,000
Nara  500  2,500-5,000
Niakunk&  200  500
Niono  500  5,000
Nioro  du  Sahel  500  *  200
Tenenkou  100  500
Timbuktu  150  or  200  500  1,500
Yanfolila  300  2,500
Yelimane  500
Yorosso  300  4,000
*  Fee  for  consultation  of  a physician.
Source: INRSP  survey,  July-September  1988.- 36 -
Annex  2
STRUCTURE  OF HEALTH  SHOP  SELLING  PRICE
The  drug cost  paid  by the  patient  breaks  down  as follows,  per  CFAF 100:
CFAF
- price  paid  to supplier  for  the  drug  40.0
- price  paid  to supplier  for  consumables  or small
equipment  required  to  administer  the  drug  for
which  patient  is  not  charged  14.3
- international  transport,  insurance  and transit  costs  17.6
- transport  costs  in  Mali  1.3
- losses,  spoilage,  etc.  5.4
- distribution  costs  (salaries  and travel  expenses
of managers--one  per  arrondissement)  9.6
- recovery  against  the  selling  price  of the  drug  of
part  of health  units'  supervision  and  operating  costs  11.7- 37 -
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